An overview on acute kidney injury in COVID-19

SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presentation may include urinary alterations, such as proteinuria and hematuria, accompanied with reduced renal function, or not. Acute kidney injury (AKI) is not uncommon, especially among critically ill patients hospitalized in intensive care unit. AKI is a negative prognostic factor and is associated with high in-hospital mortality. An early diagnosis of AKI and the assessment of any risk factors allow the nephrologist to implement appropriate therapeutic strategies, such as pharmacological or extracorporeal support. Still, mortality in patients with AKI during COVID-19 remains high. COVID-19 AKI is a quickly evolving field of study.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia - 38(2021), 3 vom: 24. Juni

Sprache:

Italienisch

Beteiligte Personen:

Altobelli, Claudia [VerfasserIn]
de Pascale, Emanuela [VerfasserIn]
Di Natale, Gabriella [VerfasserIn]
Marinelli, Gaia [VerfasserIn]
Minco, Maristella [VerfasserIn]
Mirenghi, Francesco [VerfasserIn]
Russo, Roberta [VerfasserIn]
Pluvio, Corrado [VerfasserIn]

Themen:

AKI
COVID-19
CRRT
Extracorporeal purification therapies
Journal Article
Ospedale Domenico Cotugno
Review

Anmerkungen:

Date Completed 02.07.2021

Date Revised 07.12.2022

published: Electronic

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM327168390